Clinical practice update of antifungal prophylaxis in immunocompromised children

Due to the rise in the number and types of immunosuppressed patients, invasive fungal infections (IFI) are an increasing and major cause of morbidity and mortality in immunocompromised adults and children. There is a broad group of pediatric patients at risk for IFI in whom primary and/or secondary...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, José Tomás, Romero, Concepción Alba, Belda, Sylvia, Candel, Francisco Javier, Gallego, Begoña Carazo, Fernández-Polo, Aurora, Antolín, Laura Ferreras, Colino, Carmen Garrido, Navarro, María Luisa, Neth, Olaf, Olbrich, Peter, Rincón-López, Elena, Contreras, Jesús Ruiz, Soler-Palacín, Pere
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedad Española de Quimioterapia 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790888/
https://www.ncbi.nlm.nih.gov/pubmed/31507152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6790888/
https://www.ncbi.nlm.nih.gov/pubmed/31507152

Ejemplares similares